Abcodia is an innovative company engaged in the validation and discovery of molecular biomarkers for disease diagnosis and screening.

Acacia Pharma has generated a pipeline of product opportunities addressing a range of cancer supportive care indications, such as nausea and vomiting, xerostomia and cachexia, using a commercially driven approach to product development by identifying new uses for already marketed drugs.

Adder designs and manufactures an advanced range of KVM switches, extenders and IP solutions which enable the reliable control of local, remote and global IT systems.

Established by former ARM executives in 2010 as a privately-funded power electronics company, the vision of Amantys is to transform the design, implementation and control of power electronic systems.

Arcus Global software, tools and concepts are contributing greatly to the advancement of cloud computing in the public sector.

Founded in 2002, ArtVPS quickly became established as the leading innovator of dedicated rendering hardware, developing the first processor designed exclusively to accelerate ray-tracing of 3D data.

Cambridge based Audio Analytic produces software that automatically recognises sounds by means of computer analysis.

Augmentra, a specialist in developing location-based mapping solutions for the non-urban environment, develops and markets ViewRanger, which maximises the opportunities offered by the convergence of mobile phone, imaging, and GPS technologies.

Aveillant offers Holographic Radar™ Solutions, primarily for Air Traffic Control around wind farms.

Avita’s regenerative and tissue-engineered products provide revolutionary solutions using a patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects.

Bicycle Therapeutics is a biotech company developing a platform technology that enables the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals to create highly specific and highly stable drugs.

BlueGnome was founded in Cambridge in 2002 by a team of scientists who developed a novel mathematical technology for the analysis of genetic data following the sequencing of the human genome in 2000.

Breathing Buildings was formed as a spin out company from the University of Cambridge in 2006, following the discovery and development of the proprietary low energy e-stack mixing ventilation system as part of a major research programme at the BP Institute, through the Cambridge-MIT Institute, with funding from BP plc.

Cambridge Carbon Capture is an early-stage developer of unique and scalable electrochemical mineral carbonation technology.

Cambridge Intelligence has created competing technology to Wall Street giant, IBM with a new visualisation platform.

Based at the Cambridge University Engineering Department, the company is developing carbon nanotube technology (both multiwall and single wall) for a variety of applications which include electron guns, displays, vacuum and solid state electronic applications.